Advanced search
Publication Cover
Emerging Drugs Volume 3, 1998 - Issue 1
Journal homepage
22
Views
0
CrossRef citations to date
0
Altmetric
Review

Therapeutic vaccines

Arthur Rushton Proteus International plc, Beechfield House, Lyme Green Business Park, Macclesfield, Cheshire, SK11 0JL, UK.
Pages 353-364 | Published online: 24 Feb 2005

Bibliography

  • Cohen S, Shafferman A (Eds.), Plenum Press, New York (1996):183–189.
  • BLAMEY RW: The introduction of the LHRH agonist, goserelin (7oladex') into clinical practice for endocrine-related cancer. JOURNAL (1997) 4:229–232.
  • APHTON CORPORATION, INC.: Corporate Statements. http://www.aphton.com
  • GLOVER JF, EN WRIGHT WJ, RUSHTON A: A GnRH analogue based immunotherapeutic for the palliative therapy of prostate cancer: pharmacological studies in the rat. British Prostate Group Meeting. York, UK (March 1996) :31. Abstract.
  • PROTEUS INTERNATIONAL PLC: Annual Report and Accounts (1997). http://www.proteus.co.uk.
  • New antiplatelet drugs. Drugs & Market Development (1997) 8(3):56–57.
  • HERSEY P: Melanoma vaccines: prospects for the treatment of melanoma. Exp. Opin. Invest. Drugs (1997) 6(3):267–277.
  • SPITLER LE, HARRIS DT, MASTRANGELO MJ, et al.: Clinical trials of cancer vaccines. Proceedings of the 3rd International Conference on Engineered Vaccines for Cancer and AIDS. Cambridge Symposia (1996).
  • APHTON CORPORATION, INC.: Corporate Statements. http://www.aphton.com
  • PROTEUS INTERNATIONAL PLC: Press Release (5 March 1998). http://www.proteus.co.uk.
  • NEEFJES JJ, MOMBURG F: Cell biology of antigen presentation. Curr. Opin. Immunol. (1993) 5:27–34.
  • ENGELHARD VH: How cells process antigens. Sci. Am. (August 1994):44–51.
  • GREGORIADIS G: Immunological adjuvants: a role for liposomes. Immunology Today (1990) 11(3):89–97.
  • BREWER JM, ALEXANDER J: Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control. Vaccine (1994) 12(7):613–619.
  • GUPTA RK, RELYVELD EH, LINDBLAD EB, et al.: Adjuvants - a balance between toxicity and adjuvanticity. Vaccine (1993) 11 (3) :293–305.
  • BOON T: Teaching the immune system to fight cancer. Sci. Am. (March 1993):32–39.
  • DONNELLY JJ, ULMER JB, LIU MA: Immunisation with polynucleotides: a novel approach to vaccination. The Immunologist (1994) 2(1) :20–26.
  • POWDERJECT PHARMACEUTICALS PLC: Powderject & GlaxoWellcome sign DNA vaccine agreement. Press Release (5 March 1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.